Literature DB >> 29417400

Pediatric neuro-oncology survival disparities in California.

Tabitha Cooney1, Paul G Fisher1, Li Tao2, Christina A Clarke2,3, Sonia Partap4.   

Abstract

The objective of this study was to investigate racial/ethnic differences in survival for pediatric high-grade glioma (HGG) and medulloblastoma in the state of California. We obtained data from the California Cancer Registry on 552 high-grade glioma patients (110 brainstem, 442 non-brainstem) and 648 medulloblastoma patients ages 0-19 years from 1988 to 2012. Using multivariate Cox proportional hazards regression, we examined the impact of individual and neighborhood characteristics on survival. Socioeconomic quintile and insurance status differed significantly by race for both diagnoses. Hispanic children with non-brainstem HGG had worse survival than non-Hispanic white children: hazard ratio (HR) 1.62; 95% confidence interval (CI) 1.24-2.11, but the difference was mitigated some by accounting for socioeconomic status (HR 1.48, CI 1.10-1.99). Racial/ethnic differences in survival exist for children with high-grade glioma, particularly Hispanic children with non-brainstem high-grade glioma, and are likely related to sociologic factors.

Entities:  

Keywords:  Disparity; High-grade glioma; Medulloblastoma; Pediatric; Survival

Mesh:

Year:  2018        PMID: 29417400     DOI: 10.1007/s11060-018-2773-0

Source DB:  PubMed          Journal:  J Neurooncol        ISSN: 0167-594X            Impact factor:   4.130


  43 in total

1.  Equal participation of minority patients in U.S. national pediatric cancer clinical trials.

Authors:  W A Bleyer; H A Tejeda; S B Murphy; O W Brawley; M A Smith; R S Ungerleider
Journal:  J Pediatr Hematol Oncol       Date:  1997 Sep-Oct       Impact factor: 1.289

2.  Disparities in breast cancer survival among Asian women by ethnicity and immigrant status: a population-based study.

Authors:  Scarlett Lin Gomez; Christina A Clarke; Sarah J Shema; Ellen T Chang; Theresa H M Keegan; Sally L Glaser
Journal:  Am J Public Health       Date:  2010-03-18       Impact factor: 9.308

3.  The impact of age and race on longevity in pediatric astrocytic tumors: A population-based study.

Authors:  M Constantine Samaan; Noori Akhtar-Danesh
Journal:  Pediatr Blood Cancer       Date:  2015-04-08       Impact factor: 3.167

4.  Analysis of risk factors and survival in pediatric high-grade spinal cord astrocytoma: a population-based study.

Authors:  Sandi Lam; Yimo Lin; Stephanie Melkonian
Journal:  Pediatr Neurosurg       Date:  2013-07-20       Impact factor: 1.162

5.  Measures of racial/ethnic health disparities in cancer mortality rates and the influence of socioeconomic status.

Authors:  Kenneth C Chu; Barry A Miller; Sanya A Springfield
Journal:  J Natl Med Assoc       Date:  2007-10       Impact factor: 1.798

6.  Effect of socioeconomic position on survival after childhood cancer in Denmark.

Authors:  Sofie B Simony; Lasse W Lund; Friederike Erdmann; Klaus K Andersen; Jeanette F Winther; Joachim Schüz; Christoffer Johansen; Kjeld Schmiegelow; Susanne O Dalton
Journal:  Acta Oncol       Date:  2016-03-03       Impact factor: 4.089

7.  Racial/ethnic diversity in children's oncology clinical trials: ten years later.

Authors:  Mary Jo Lund; Mark T Eliason; Ann E Haight; Kevin C Ward; John L Young; Rebecca D Pentz
Journal:  Cancer       Date:  2009-08-15       Impact factor: 6.860

8.  Analysis of survival in pediatric high-grade brainstem gliomas: A population-based study.

Authors:  Sandi Lam; Yimo Lin; Brenda Auffinger; Stephanie Melkonian
Journal:  J Pediatr Neurosci       Date:  2015 Jul-Sep

Review 9.  Pediatric high-grade glioma: biologically and clinically in need of new thinking.

Authors:  Chris Jones; Matthias A Karajannis; David T W Jones; Mark W Kieran; Michelle Monje; Suzanne J Baker; Oren J Becher; Yoon-Jae Cho; Nalin Gupta; Cynthia Hawkins; Darren Hargrave; Daphne A Haas-Kogan; Nada Jabado; Xiao-Nan Li; Sabine Mueller; Theo Nicolaides; Roger J Packer; Anders I Persson; Joanna J Phillips; Erin F Simonds; James M Stafford; Yujie Tang; Stefan M Pfister; William A Weiss
Journal:  Neuro Oncol       Date:  2017-02-01       Impact factor: 12.300

10.  Integrated Molecular Meta-Analysis of 1,000 Pediatric High-Grade and Diffuse Intrinsic Pontine Glioma.

Authors:  Alan Mackay; Anna Burford; Diana Carvalho; Elisa Izquierdo; Janat Fazal-Salom; Kathryn R Taylor; Lynn Bjerke; Matthew Clarke; Mara Vinci; Meera Nandhabalan; Sara Temelso; Sergey Popov; Valeria Molinari; Pichai Raman; Angela J Waanders; Harry J Han; Saumya Gupta; Lynley Marshall; Stergios Zacharoulis; Sucheta Vaidya; Henry C Mandeville; Leslie R Bridges; Andrew J Martin; Safa Al-Sarraj; Christopher Chandler; Ho-Keung Ng; Xingang Li; Kun Mu; Saoussen Trabelsi; Dorra H'mida-Ben Brahim; Alexei N Kisljakov; Dmitry M Konovalov; Andrew S Moore; Angel Montero Carcaboso; Mariona Sunol; Carmen de Torres; Ofelia Cruz; Jaume Mora; Ludmila I Shats; João N Stavale; Lucas T Bidinotto; Rui M Reis; Natacha Entz-Werle; Michael Farrell; Jane Cryan; Darach Crimmins; John Caird; Jane Pears; Michelle Monje; Marie-Anne Debily; David Castel; Jacques Grill; Cynthia Hawkins; Hamid Nikbakht; Nada Jabado; Suzanne J Baker; Stefan M Pfister; David T W Jones; Maryam Fouladi; André O von Bueren; Michael Baudis; Adam Resnick; Chris Jones
Journal:  Cancer Cell       Date:  2017-09-28       Impact factor: 31.743

View more
  9 in total

1.  Racial and ethnic differences in survival of pediatric patients with brain and central nervous system cancer in the United States.

Authors:  David A Siegel; Jun Li; Helen Ding; Simple D Singh; Jessica B King; Lori A Pollack
Journal:  Pediatr Blood Cancer       Date:  2018-10-23       Impact factor: 3.167

Review 2.  Racial and ethnic disparities among children with primary central nervous system tumors in the US.

Authors:  Edwin Nieblas-Bedolla; Briana Christophers; John R Williams; Alexandra Power-Hays; Nathalia Jimenez; Analiz Rodriguez
Journal:  J Neurooncol       Date:  2021-03-28       Impact factor: 4.130

3.  Racial/ethnic, socioeconomic, and geographic survival disparities in adolescents and young adults with primary central nervous system tumors.

Authors:  Vidya Puthenpura; Maureen E Canavan; Jenny N Poynter; Michael Roth; Farzana D Pashankar; Beth A Jones; Asher M Marks
Journal:  Pediatr Blood Cancer       Date:  2021-03-11       Impact factor: 3.167

4.  Population-Based Analysis of Demographic and Socioeconomic Disparities in Pediatric CNS Cancer Survival in the United States.

Authors:  Robert Fineberg; Shadi Zahedi; Megan Eguchi; Muriel Hart; Myles Cockburn; Adam L Green
Journal:  Sci Rep       Date:  2020-03-12       Impact factor: 4.379

5.  Maternal and perinatal factors are associated with risk of pediatric central nervous system tumors and poorer survival after diagnosis.

Authors:  Maral Adel Fahmideh; Erin C Peckham-Gregory; Jeremy M Schraw; Murali Chintagumpala; Stephen C Mack; Philip J Lupo; Michael E Scheurer
Journal:  Sci Rep       Date:  2021-05-17       Impact factor: 4.379

6.  Relative survival after diagnosis with a primary brain or other central nervous system tumor in the National Program of Cancer Registries, 2004 to 2014.

Authors:  Quinn T Ostrom; Gabrielle Truitt; Haley Gittleman; Daniel J Brat; Carol Kruchko; Reda Wilson; Jill S Barnholtz-Sloan
Journal:  Neurooncol Pract       Date:  2019-12-16

7.  Disparities in Pediatric Oncology: The 21st Century Opportunity to Improve Outcomes for Children and Adolescents With Cancer.

Authors:  Paula Aristizabal; Lena E Winestone; Puja Umaretiya; Kira Bona
Journal:  Am Soc Clin Oncol Educ Book       Date:  2021-06

Review 8.  Social determinants of health and pediatric cancer survival: A systematic review.

Authors:  Yvette H Tran; Scott L Coven; Seho Park; Eneida A Mendonca
Journal:  Pediatr Blood Cancer       Date:  2022-02-02       Impact factor: 3.838

Review 9.  Neighborhood Characteristics and Cancer Survivorship: An Overview of the Current Literature on Neighborhood Landscapes and Cancer Care.

Authors:  Sima Namin; Yuhong Zhou; Joan Neuner; Kirsten Beyer
Journal:  Int J Environ Res Public Health       Date:  2021-07-05       Impact factor: 3.390

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.